You can read the full article at Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial Obesity is a major public health issue worldwide
Development of SGLT1 and SGLT2 inhibitors
These appointments provide an opportunity to discuss any concerns about side effects, dietary supplements, or overall diabetes management
The cardiovascular benefits demonstrated in the SELECT trial were at the 2.4 mg Wegovy dose, not at the lower Ozempic doses
The imputation model was a linear regression of the endpoint with gender as factor and baseline value of the endpoint, timing and the value of last available observation on study (LAO-OS) of the endpoint as covariates, imputed by treatment status
What about hypoglycemia risk: Basaglar vs Ozempic